Article
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
13 May 2022
Abstract excerpt
Allogeneic chimeric antigen receptor T-cell (CART) therapies require multiple gene edits to be clinically tractable. Most allogeneic CARTs have been created using gene editing techniques that induce DNA double-stranded breaks (DSBs), resulting in unintended on-target editing outcomes with potentially unforeseen consequences. Cytosine base editors (CBEs) install C•G to T•A point mutations in T cells, with between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
